21 May 2013
Keywords: cat, losses, widen, chief, executive, decides, move
Article | 27 November 2001
Cambridge Antibody Technologies of the UK has posted pretax losses ofL11.8 million ($16.6 million) for the year ended September 2001, up from
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 January 2002
20 May 2013
© 2013 thepharmaletter.com